aim to enhance its balance sheets and improve their financial strength, the Company intends to extend the loan tenor from September 30, 2017 to November 15, 2017. This financial support is deemed as

more than 0.03% but less than 3% of book value of Net Tangible Assets (the reviewed of the consolidated financial statement as at 30 June 2017). Therefore, the company would need to disclose this

operations incurred compared to total revenues were 65.8% and 68.6% repectively. This increase stemmed from doctor fee, renumeration, and any other fringe benefits, which resulted from the increase of Medical

net profit from continuing operations the amount of Baht 40.27 million an increase of Baht 38.86 million or 2,756.03% from the same period of last year due to this period, and net profit from

more than 0.03% but less than 3% of book value of Net Tangible Assets (the reviewed of the consolidated financial statement as at 30 September 2017). Therefore, the company would need to disclose this

Corporation PCL. This amalgamation in accounting aspect has to be a sell of existing subsidiary, and then invest in the new bio-fuel company instead (KSL’s new associated company). As a result, the Company

    remain the same). In this regard, the Company shall notify if there is any development on this matter. Please be informed accordingly Yours faithfully Mr.Thepchai Sae Yong Chief Executive Officer   F 24-1

by 20.8%. This represent net profit margin of 0.91%. The major reasons for the Company’s net profit increasing were the Company can achieve a higher total revenues and gain from fair value adjustment

follows: The Company’s Performance for the yearly end in 2017 showed a Net Profit of 6.4 million baht, higher than 2016 by 1.2 million baht or an increased by 20.8%. This represent net profit margin of 0.91

environment and community. This has led the Company to be trusted and accepted internationally. The Company re-affirms that we will strive to operate our business in the best interest of our stakeholders, in a